Brown Advisory’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482K | Buy |
12,191
+165
| +1% | +$6.52K | ﹤0.01% | 1024 |
|
|
2025
Q1 | $363K | Sell |
12,026
-704
| -6% | -$21.2K | ﹤0.01% | 1079 |
|
|
2024
Q4 | $445K | Sell |
12,730
-16
| -0.1% | -$559 | ﹤0.01% | 1050 |
|
|
2024
Q3 | $511K | Buy |
12,746
+1,780
| +16% | +$71.3K | ﹤0.01% | 991 |
|
|
2024
Q2 | $523K | Sell |
10,966
-156
| -1% | -$7.44K | ﹤0.01% | 947 |
|
|
2024
Q1 | $482K | Sell |
11,122
-422
| -4% | -$18.3K | ﹤0.01% | 954 |
|
|
2023
Q4 | $584K | Sell |
11,544
-181
| -2% | -$9.16K | ﹤0.01% | 894 |
|
|
2023
Q3 | $532K | Buy |
11,725
+138
| +1% | +$6.26K | ﹤0.01% | 890 |
|
|
2023
Q2 | $475K | Buy |
11,587
+126
| +1% | +$5.17K | ﹤0.01% | 920 |
|
|
2023
Q1 | $410K | Sell |
11,461
-70
| -0.6% | -$2.5K | ﹤0.01% | 964 |
|
|
2022
Q4 | $436K | Buy |
11,531
+901
| +8% | +$34K | ﹤0.01% | 939 |
|
|
2022
Q3 | $470K | Buy |
10,630
+1,000
| +10% | +$44.2K | ﹤0.01% | 872 |
|
|
2022
Q2 | $357K | Buy |
+9,630
| New | +$357K | ﹤0.01% | 919 |
|
|
2016
Q2 | – | Sell |
-5,369
| Closed | -$218K | – | 1068 |
|
|
2016
Q1 | $218K | Sell |
5,369
-11
| -0.2% | -$447 | ﹤0.01% | 907 |
|
|
2015
Q4 | $333K | Sell |
5,380
-467
| -8% | -$28.9K | ﹤0.01% | 770 |
|
|
2015
Q3 | $237K | Buy |
+5,847
| New | +$237K | ﹤0.01% | 848 |
|
|
2015
Q2 | – | Sell |
-5,665
| Closed | -$361K | – | 893 |
|
|
2015
Q1 | $361K | Buy |
5,665
+80
| +1% | +$5.1K | ﹤0.01% | 772 |
|
|
2014
Q4 | $345K | Buy |
+5,585
| New | +$345K | ﹤0.01% | 773 |
|